Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: Implications for malaria transmission control programmes

Tropical Medicine and International Health

Volumn 2, Issue 3, 1997, Pages 227-229

  Puta, Chilunga ^a   Manyando, Christine ^a  

^a TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

Author keywords

chloroquine; Fansidar; gametocytes; malaria transmission; Plasmodium falciparum; Zambia

Indexed keywords

CHLOROQUINE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GAMETOCYTE; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; ZAMBIA;

PLASMODIUM FALCIPARUM; VERTEBRATA;

EID: 0030941690     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1997.d01-267.x     Document Type: Article

References (5)

1. Babiker H, Ranford-Cartwright L, Sultan A, Satti G & Walliker D (1994) Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 328-331.
2. Bloland PB, Lackritz ME, Kazembe PN, Were JB, Steketee R & Campbell CC (1993) Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases 167, 932-937.
3. Unicef (1994) Report of the 5th Malaria Networking Meeting Arusha, Tanzania 23-24 May, pp. 57-65.
4. Wernsdorfer WH (1991) The development and spread of drug resistant malaria. Parasitology Today 7, 297-302.
5. WHO (1991) Basic Laboratory Methods in Medical Parasitology. WHO, Geneva.